Nakamura A - Search Results

1

Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer.

Sugimoto M, Furuta T, Shirai N, Nakamura A, Xiao F, Kajimura M, Sugimura H, Hishida A. Sugimoto M, et al. Among authors: nakamura a. J Gastroenterol Hepatol. 2007 Jan;22(1):51-9. doi: 10.1111/j.1440-1746.2006.04442.x. J Gastroenterol Hepatol. 2007. PMID: 17201881

2

Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction method.

Nakamura A, Furuta T, Shirai N, Sugimoto M, Kajimura M, Soya Y, Hishida A. Nakamura A, et al. J Gastroenterol Hepatol. 2007 Jul;22(7):1057-63. doi: 10.1111/j.1440-1746.2006.04546.x. J Gastroenterol Hepatol. 2007. PMID: 17608851

3

Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects.

Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A. Sugimoto M, et al. Among authors: nakamura a. J Gastroenterol Hepatol. 2007 Sep;22(9):1443-9. doi: 10.1111/j.1440-1746.2006.04613.x. J Gastroenterol Hepatol. 2007. PMID: 17716348

4

Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.

Furuta T, Soya Y, Sugimoto M, Shirai N, Nakamura A, Kodaira C, Nishino M, Okuda M, Okimoto T, Murakami K, Fujioka T, Hishida A. Furuta T, et al. Among authors: nakamura a. J Gastroenterol Hepatol. 2007 Nov;22(11):1810-5. doi: 10.1111/j.1440-1746.2007.04919.x. J Gastroenterol Hepatol. 2007. PMID: 17914955

5

Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.

Furuta T, Sagehashi Y, Shirai N, Sugimoto M, Nakamura A, Kodaira M, Kenmotsu K, Nagano M, Egashira T, Ueda K, Yoneyama M, Ohashi K, Ishizaki T, Hishida A. Furuta T, et al. Among authors: nakamura a. Clin Gastroenterol Hepatol. 2005 Jun;3(6):564-73. doi: 10.1016/s1542-3565(04)00779-7. Clin Gastroenterol Hepatol. 2005. PMID: 15952098

6

Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.

Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A, Ishizaki T. Sugimoto M, et al. Among authors: nakamura a. Aliment Pharmacol Ther. 2005 Nov 15;22(10):1033-40. doi: 10.1111/j.1365-2036.2005.02678.x. Aliment Pharmacol Ther. 2005. PMID: 16268979 Free article.

7

[Susceptibility to antibiotics and drug metabolism in patients with H. pylori infection refractory to the initial treatment--therapeutic strategy based on susceptibility to CAM and CYP2C19 polymorphism].

Furuta T, Sugimoto M, Nakamura A, Shirai N. Furuta T, et al. Among authors: nakamura a. Nihon Rinsho. 2005 Nov;63 Suppl 11:426-33. Nihon Rinsho. 2005. PMID: 16363573 Review. Japanese. No abstract available.

8

[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].

Shirai N, Furuta T, Sugimoto M, Nakamura A. Shirai N, et al. Among authors: nakamura a. Nihon Rinsho. 2005 Nov;63 Suppl 11:438-41. Nihon Rinsho. 2005. PMID: 16363575 Review. Japanese. No abstract available.

9

Maintenance time of sedative effects after an intravenous infusion of diazepam: a guide for endoscopy using diazepam.

Sugimoto M, Furuta T, Nakamura A, Shirai N, Ikuma M, Misaka S, Uchida S, Watanabe H, Ohashi K, Ishizaki T, Hishida A. Sugimoto M, et al. Among authors: nakamura a. World J Gastroenterol. 2008 Sep 7;14(33):5197-203. doi: 10.3748/wjg.14.5197. World J Gastroenterol. 2008. PMID: 18777597 Free PMC article.

10

Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes.

Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Hishida A, Ohashi K, Ishizaki T. Sugimoto M, et al. Among authors: nakamura a. Clin Pharmacol Ther. 2005 Apr;77(4):302-11. doi: 10.1016/j.clpt.2004.10.010. Clin Pharmacol Ther. 2005. PMID: 15903128 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,875 results

Search Page

Filters